tradingkey.logo

Australia's EBR Systems rises on first patient enrolment in CRT study

ReutersDec 12, 2025 12:25 AM

Shares of EBR Systems EBR.AX advance as much as 5.52% to A$0.955, their highest point since December 4

The medtech co reportsfirst patient enrolment and implant in a totally leadless cardiac resynchronization therapy (CRT) study, which could "meaningfully expand" its addressable market

Adds that the study marks a key milestone as it tests WiSE for a potential first-line heart failure therapy

Stock down 9.3% YTD, including the day's moves

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI